KRAS and non-small cell lung carcinoma: We compared our cohort with TCGA Caucasians cohort to explore the mutation profile in Chinese NSCLC patients, the mutation frequency of EGFR, KRAS, DDR2, ERBB2, and MET in our cohort is different from the frequency in TCGA cohort.